0001437749-17-016405.txt : 20170927 0001437749-17-016405.hdr.sgml : 20170927 20170927165452 ACCESSION NUMBER: 0001437749-17-016405 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170925 FILED AS OF DATE: 20170927 DATE AS OF CHANGE: 20170927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamel Lawrence G CENTRAL INDEX KEY: 0001511368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 171104767 MAIL ADDRESS: STREET 1: C/O ACELRX PHARMACEUTICALS INC. STREET 2: 575 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 rdgdoc.xml FORM 4 X0306 4 2017-09-25 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001511368 Hamel Lawrence G C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 Chief Development Officer Common Stock 2017-09-25 4 S 0 13827 D 68504 I See footnote 52,125 of the Shares are held in the Hamel Revocable Living Trust The Shares were sold in a range from $3.50-$4.50 Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan /s/ Martha Adler, as attorney-in-fact 2017-09-27